Rheumatology Unit, Hôpital de la Cavale Blanche, Brest 29609, France; INSERM U1227, Université de Brest, LabEx IGO, 29609 Brest, France.
Rheumatology Unit, Hôpital de la Cavale Blanche, Brest 29609, France; INSERM U1227, Université de Brest, LabEx IGO, 29609 Brest, France.
Joint Bone Spine. 2018 Mar;85(2):227-232. doi: 10.1016/j.jbspin.2017.02.007. Epub 2017 Feb 27.
To evaluate whether major salivary-gland ultrasonography (SGUS) abnormalities change over time in patients with suspected primary Sjögren's syndrome (pSS) during the natural course of the disease.
We studied patients with suspected pSS who were included in the Brittany cohort of suspected pSS and underwent SGUS at least twice, as part of the routine diagnostic workup done at baseline then at least 1 year later as an additional investigation deemed appropriate by the physician. The evaluation criteria were the semi-quantitative SGUS score (0-4) for each parotid and submandibular gland, the highest SGUS score among the four glands, and the sum of SGUS scores for the four glands. These scores were compared in patients with and without pSS according to the workup at baseline, and their changes over time were assessed.
Of 49 included patients, 29 received a diagnosis of pSS at baseline; none of the remaining 20 patients was diagnosed with pSS at either evaluation. The mean (SD) sum of SGUS scores at baseline was 8.9 (5.6) in patients with and 2.1 (2.9) in those without pSS (P<0.01). Mean time between SGUSs was 1.9 (1.6) years. None of the evaluation criteria changed between the two SGUSs in the overall population, pSS group, or group without pSS. Similar results were found in the subgroup with recent-onset symptoms.
SGUS abnormalities assessed using a semi-quantitative score did not change significantly during a follow-up of nearly 2 years after an initial evaluation for suspected pSS.
评估在原发性干燥综合征(pSS)患者的自然病程中,主要涎腺超声(SGUS)异常是否随时间变化。
我们研究了疑似 pSS 患者,这些患者包括在 Brittany 疑似 pSS 队列中,并且至少进行了两次 SGUS 检查,作为基线时常规诊断工作的一部分,然后至少在 1 年后,由医生认为适当的额外检查。评估标准是每个腮腺和颌下腺的半定量 SGUS 评分(0-4)、四个腺体中最高的 SGUS 评分以及四个腺体的 SGUS 评分总和。根据基线检查比较了有和无 pSS 的患者的这些评分,并评估了它们随时间的变化。
在纳入的 49 名患者中,29 名在基线时被诊断为 pSS;其余 20 名患者在两次评估中均未被诊断为 pSS。基线时 SGUS 评分总和的平均值(标准差)在有 pSS 的患者中为 8.9(5.6),在无 pSS 的患者中为 2.1(2.9)(P<0.01)。两次 SGUS 检查之间的平均时间为 1.9(1.6)年。在总体人群、pSS 组或无 pSS 组中,所有评估标准在两次 SGUS 检查之间均未发生变化。在近期发病症状的亚组中也发现了类似的结果。
在疑似 pSS 的初始评估后近 2 年的随访期间,使用半定量评分评估的 SGUS 异常没有显著变化。